187 related articles for article (PubMed ID: 37873189)
1. ARF6-dependent endocytic trafficking of the Interferon-γ receptor drives adaptive immune resistance in cancer.
Wee Y; Wang J; Wilson EC; Rich CP; Rogers A; Tong Z; DeGroot E; Gopal YNV; Davies MA; Ekiz HA; Tay JKH; Stubben C; Boucher KM; Oviedo JM; Fairfax KC; Williams MA; Holmen SL; Wolff RK; Grossmann AH
bioRxiv; 2023 Oct; ():. PubMed ID: 37873189
[TBL] [Abstract][Full Text] [Related]
2. Arf6-driven endocytic recycling of CD147 determines HCC malignant phenotypes.
Qi S; Su L; Li J; Zhang C; Ma Z; Liu G; Zhang Q; Jia G; Piao Y; Zhang S
J Exp Clin Cancer Res; 2019 Nov; 38(1):471. PubMed ID: 31752956
[TBL] [Abstract][Full Text] [Related]
3. Virus Control of Trafficking from Sorting Endosomes.
Zeltzer S; Zeltzer CA; Igarashi S; Wilson J; Donaldson JG; Goodrum F
mBio; 2018 Jul; 9(4):. PubMed ID: 30042195
[TBL] [Abstract][Full Text] [Related]
4. ADP Ribosylation Factor 6 Regulates Neuronal Migration in the Developing Cerebral Cortex through FIP3/Arfophilin-1-dependent Endosomal Trafficking of N-cadherin.
Hara Y; Fukaya M; Hayashi K; Kawauchi T; Nakajima K; Sakagami H
eNeuro; 2016; 3(4):. PubMed ID: 27622210
[TBL] [Abstract][Full Text] [Related]
5. BRAG2a Mediates mGluR-Dependent AMPA Receptor Internalization at Excitatory Postsynapses through the Interaction with PSD-95 and Endophilin 3.
Fukaya M; Sugawara T; Hara Y; Itakura M; Watanabe M; Sakagami H
J Neurosci; 2020 May; 40(22):4277-4296. PubMed ID: 32341099
[TBL] [Abstract][Full Text] [Related]
6. P53- and mevalonate pathway-driven malignancies require Arf6 for metastasis and drug resistance.
Hashimoto A; Oikawa T; Hashimoto S; Sugino H; Yoshikawa A; Otsuka Y; Handa H; Onodera Y; Nam JM; Oneyama C; Okada M; Fukuda M; Sabe H
J Cell Biol; 2016 Apr; 213(1):81-95. PubMed ID: 27044891
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Testing of Chemotherapy and Immune Checkpoint Blockade in Preclinical Cancer Models Identifies Additive Combinations.
Principe N; Aston WJ; Hope DE; Tilsed CM; Fisher SA; Boon L; Dick IM; Chin WL; McDonnell AM; Nowak AK; Lake RA; Chee J; Lesterhuis WJ
Front Immunol; 2022; 13():872295. PubMed ID: 35634282
[TBL] [Abstract][Full Text] [Related]
8. Abrogation of ARF6 promotes RSL3-induced ferroptosis and mitigates gemcitabine resistance in pancreatic cancer cells.
Ye Z; Hu Q; Zhuo Q; Zhu Y; Fan G; Liu M; Sun Q; Zhang Z; Liu W; Xu W; Ji S; Yu X; Xu X; Qin Y
Am J Cancer Res; 2020; 10(4):1182-1193. PubMed ID: 32368394
[TBL] [Abstract][Full Text] [Related]
9. Ral-Arf6 crosstalk regulates Ral dependent exocyst trafficking and anchorage independent growth signalling.
Pawar A; Meier JA; Dasgupta A; Diwanji N; Deshpande N; Saxena K; Buwa N; Inchanalkar S; Schwartz MA; Balasubramanian N
Cell Signal; 2016 Sep; 28(9):1225-1236. PubMed ID: 27269287
[TBL] [Abstract][Full Text] [Related]
10. Decoupling of activation and effector binding underlies ARF6 priming of fast endocytic recycling.
Montagnac G; de Forges H; Smythe E; Gueudry C; Romao M; Salamero J; Chavrier P
Curr Biol; 2011 Apr; 21(7):574-9. PubMed ID: 21439824
[TBL] [Abstract][Full Text] [Related]
11. Grp1-associated scaffold protein (GRASP) is a regulator of the ADP ribosylation factor 6 (Arf6)-dependent membrane trafficking pathway.
Venkataraman A; Nevrivy DJ; Filtz TM; Leid M
Cell Biol Int; 2012; 36(12):1115-28. PubMed ID: 22931251
[TBL] [Abstract][Full Text] [Related]
12. ARF6-Rac1 signaling-mediated neurite outgrowth is potentiated by the neuronal adaptor FE65 through orchestrating ARF6 and ELMO1.
Chan WWR; Li W; Chang RCC; Lau KF
FASEB J; 2020 Dec; 34(12):16397-16413. PubMed ID: 33047393
[TBL] [Abstract][Full Text] [Related]
13. The adaptor complex AP-2 regulates post-endocytic trafficking through the non-clathrin Arf6-dependent endocytic pathway.
Lau AW; Chou MM
J Cell Sci; 2008 Dec; 121(Pt 24):4008-17. PubMed ID: 19033387
[TBL] [Abstract][Full Text] [Related]
14. MIF inhibition as a strategy for overcoming resistance to immune checkpoint blockade therapy in melanoma.
de Azevedo RA; Shoshan E; Whang S; Markel G; Jaiswal AR; Liu A; Curran MA; Travassos LR; Bar-Eli M
Oncoimmunology; 2020 Dec; 9(1):1846915. PubMed ID: 33344042
[TBL] [Abstract][Full Text] [Related]
15. The small GTPase Arf6 is essential for the Tram/Trif pathway in TLR4 signaling.
Van Acker T; Eyckerman S; Vande Walle L; Gerlo S; Goethals M; Lamkanfi M; Bovijn C; Tavernier J; Peelman F
J Biol Chem; 2014 Jan; 289(3):1364-76. PubMed ID: 24297182
[TBL] [Abstract][Full Text] [Related]
16. ADP-ribosylation factor 6 modulates adrenergic stimulated lipolysis in adipocytes.
Liu Y; Zhou D; Abumrad NA; Su X
Am J Physiol Cell Physiol; 2010 Apr; 298(4):C921-8. PubMed ID: 20107045
[TBL] [Abstract][Full Text] [Related]
17. Modeling resistance of colorectal peritoneal metastases to immune checkpoint blockade in humanized mice.
Küçükköse E; Heesters BA; Villaudy J; Verheem A; Cercel M; van Hal S; Boj SF; Borel Rinkes IHM; Punt CJA; Roodhart JML; Laoukili J; Koopman M; Spits H; Kranenburg O
J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36543378
[TBL] [Abstract][Full Text] [Related]
18. Antitumor immunity is defective in T cell-specific microRNA-155-deficient mice and is rescued by immune checkpoint blockade.
Huffaker TB; Lee SH; Tang WW; Wallace JA; Alexander M; Runtsch MC; Larsen DK; Thompson J; Ramstead AG; Voth WP; Hu R; Round JL; Williams MA; O'Connell RM
J Biol Chem; 2017 Nov; 292(45):18530-18541. PubMed ID: 28912267
[TBL] [Abstract][Full Text] [Related]
19. hMENA isoforms regulate cancer intrinsic type I IFN signaling and extrinsic mechanisms of resistance to immune checkpoint blockade in NSCLC.
Trono P; Tocci A; Palermo B; Di Carlo A; D'Ambrosio L; D'Andrea D; Di Modugno F; De Nicola F; Goeman F; Corleone G; Warren S; Paolini F; Panetta M; Sperduti I; Baldari S; Visca P; Carpano S; Cappuzzo F; Russo V; Tripodo C; Zucali P; Gregorc V; Marchesi F; Nistico P
J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37612043
[TBL] [Abstract][Full Text] [Related]
20. Pivotal role of ADP-ribosylation factor 6 in Toll-like receptor 9-mediated immune signaling.
Wu JY; Kuo CC
J Biol Chem; 2012 Feb; 287(6):4323-34. PubMed ID: 22170068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
